OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study
Paulus Rommer, Nicolaus König, Annett Sühnel, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 9, pp. 784-789
Open Access | Times Cited: 19
Paulus Rommer, Nicolaus König, Annett Sühnel, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 9, pp. 784-789
Open Access | Times Cited: 19
Showing 19 citing articles:
Polypharmacy among patients with multiple sclerosis: a qualitative systematic review
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 2, pp. 139-145
Closed Access | Times Cited: 41
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 2, pp. 139-145
Closed Access | Times Cited: 41
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
Michael Hecker, Niklas Frahm, Paula Bachmann, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Michael Hecker, Niklas Frahm, Paula Bachmann, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Importance of Coping Strategies on Quality of Life in People with Multiple Sclerosis: A Systematic Review
Laura Culicetto, Viviana Lo Buono, Sofia Donato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5505-5505
Open Access | Times Cited: 2
Laura Culicetto, Viviana Lo Buono, Sofia Donato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5505-5505
Open Access | Times Cited: 2
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
Marie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Drug Safety (2023) Vol. 14
Open Access | Times Cited: 6
Marie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Drug Safety (2023) Vol. 14
Open Access | Times Cited: 6
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Assessment of the complementary and integrative medicine utilization among patients with multiple sclerosis using a translated and adapted version of the international questionnaire (I-CAM-QP): A cross-sectional study in Southern Iran
Farinaz Farhoudi, Alireza Salehi, Mina Vojoud, et al.
Complementary Therapies in Medicine (2019) Vol. 46, pp. 47-53
Closed Access | Times Cited: 18
Farinaz Farhoudi, Alireza Salehi, Mina Vojoud, et al.
Complementary Therapies in Medicine (2019) Vol. 46, pp. 47-53
Closed Access | Times Cited: 18
Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Dark Classics in Chemical Neuroscience: An Evidence-Based Systematic Review of Belladonna
Vimal K. Maurya, Swatantra Kumar, Russell Kabir, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 23, pp. 3937-3954
Closed Access | Times Cited: 13
Vimal K. Maurya, Swatantra Kumar, Russell Kabir, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 23, pp. 3937-3954
Closed Access | Times Cited: 13
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, et al.
Therapeutic Advances in Neurological Disorders (2020) Vol. 13, pp. 175628642096950-175628642096950
Open Access | Times Cited: 13
Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, et al.
Therapeutic Advances in Neurological Disorders (2020) Vol. 13, pp. 175628642096950-175628642096950
Open Access | Times Cited: 13
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study
Aleksandra Podlecka‐Piętowska, Monika Sugalska, Katarzyna Janiszewska, et al.
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 5, pp. 428-434
Open Access | Times Cited: 6
Aleksandra Podlecka‐Piętowska, Monika Sugalska, Katarzyna Janiszewska, et al.
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 5, pp. 428-434
Open Access | Times Cited: 6
Fatigue and Self-management among Multiple Sclerosis Patients
Afnan Seraj Jamal Shawli, Iman Abdallah Mohammed Abdulmutalib, Elham Al Nagshabandi
American journal of nursing research (2019) Vol. 7, Iss. 4, pp. 550-560
Open Access | Times Cited: 6
Afnan Seraj Jamal Shawli, Iman Abdallah Mohammed Abdulmutalib, Elham Al Nagshabandi
American journal of nursing research (2019) Vol. 7, Iss. 4, pp. 550-560
Open Access | Times Cited: 6
Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review
Robert Simpson, Stephanie Posa, Tania Bruno, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1300-1322
Open Access | Times Cited: 4
Robert Simpson, Stephanie Posa, Tania Bruno, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1300-1322
Open Access | Times Cited: 4
Headache in Multiple Sclerosis - Pharmacological Aspects
Marcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.
Current Pharmaceutical Design (2021) Vol. 28, Iss. 6, pp. 445-453
Closed Access | Times Cited: 5
Marcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.
Current Pharmaceutical Design (2021) Vol. 28, Iss. 6, pp. 445-453
Closed Access | Times Cited: 5
Self-Management Guidelines: Effect on Knowledge, Fatigue, Self-Efficacy and Medications Adherence among Patients with Multiple Sclerosis
Shimaa Nabil Abd Elsalam, Rasmeia Abd Elsatar Ali
Egyptian Journal of Health Care (2022) Vol. 13, Iss. 1, pp. 1008-1024
Open Access | Times Cited: 3
Shimaa Nabil Abd Elsalam, Rasmeia Abd Elsatar Ali
Egyptian Journal of Health Care (2022) Vol. 13, Iss. 1, pp. 1008-1024
Open Access | Times Cited: 3
Physiological, Anatomical and Physicochemical Characteristics of Children Affecting Food-Drug Interaction-Review
Kamal A. Attia
Pakistan Journal of Biological Sciences (2024) Vol. 27, Iss. 1, pp. 1-7
Open Access
Kamal A. Attia
Pakistan Journal of Biological Sciences (2024) Vol. 27, Iss. 1, pp. 1-7
Open Access
Literaturverzeichnis zum Titel: Zettl/Sieb: Diagnostik und Therapie neurologischer Erkrankungen, 6.A. 2024
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Clinical Roundup: Selected Treatment Options for Multiple Sclerosis—Part 2
Alternative and Complementary Therapies (2019) Vol. 25, Iss. 5, pp. 269-271
Open Access
Alternative and Complementary Therapies (2019) Vol. 25, Iss. 5, pp. 269-271
Open Access
